⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Farmak and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Farmak
↗Kyiv, Ukraine
Farmak is a leading Ukrainian pharmaceutical company, established in 1925, specializing in the research, development, and manufacturing of generic medicinal products. The company has expanded its global footprint with manufacturing and R&D facilities in Ukraine and Spain, and maintains commercial offices across Europe, the Middle East, and Asia.
With a portfolio of over 450 medicinal products and more than 1,000 marketing authorizations, Farmak operates across 14 therapeutic areas. The company is recognized for its commitment to quality, holding numerous GMP-compliant production lines, and has been a consistent leader in the Ukrainian pharmaceutical market since 2010.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1925
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Generics, API manufacturing
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Nord Farm, Farmak International S.R.O.
Key Partnerships:Veteran Hub (cooperation), Various international research collaborations
COMPETITION
Position:Leader
Competitors:Darnitsa, Arterium, Health
LEADERSHIP
Key Executives:
Filya Ivanivna Zhebrovska - Chair of the Board
Volodymyr Kostiuk - CEO
LINKS
Website:farmak.ua
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Farmak. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.